NCT03831347

Brief Summary

Phase 2: Open Trial N=12 adolescents will be enrolled into a single-arm pilot trial to test the adapted hatha yoga intervention

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable depression

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 5, 2019

Completed
24 days until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 14, 2019

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2019

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

March 23, 2022

Completed
Last Updated

March 23, 2022

Status Verified

February 1, 2022

Enrollment Period

6 months

First QC Date

January 30, 2019

Results QC Date

October 26, 2021

Last Update Submit

February 28, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Acceptability

    Acceptability assessed based on number of participants who remained in the intervention (retention).

    Post intervention (month 3)

  • Credibility Expectancy Questionnaire (CEQ) - Credibility Subscale

    Credibility assessed with Credibility Expectancy Questionnaire (CEQ), credibility subscale. The credibility subscale of the CEQ, is a 3 item subscale of the 6 item CEQ. The 3 items are scored on a range of 0-1. Higher scores indicate greater credibility.

    Week 1

  • Credibility Expectancy Questionnaire (CEQ) - Expectancy Subscale

    Patient expectations assessed with the Credibility Expectancy Questionnaire (CEQ), expectancy subscale. The expectancy subscale is a 3 item subscale of the 6 item CEQ. Score ranges from 0-1 with higher scores indicating greater expectations.

    Week 1

  • The Client Satisfaction Questionnaire (CSQ-8)

    Satisfaction with treatment assessed with The Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item measure with each item measured on a 1-4 scale, and total score range from 8-32. Higher scores indicate greater client satisfaction.

    Post intervention (month 3)

  • Home Practice Questionnaire

    Number of participants who met criteria for home practice (target of two practices per week) as assessed with a home practice questionnaire.

    Post intervention (month 3)

  • Systematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)

    Participant safety/adverse events will be measured using the SAFTEE. Participants will also be asked weekly if they experienced any injuries as a result of yoga.

    Post intervention (month 3)

Secondary Outcomes (1)

  • Quick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)

    post intervention (month 3)

Study Arms (1)

Hatha Yoga

EXPERIMENTAL

12 weeks of modified Hatha Yoga specifically designed to be administered to teens with depression.

Behavioral: Hatha Yoga

Interventions

Hatha YogaBEHAVIORAL

12 weeks of Hatha Yoga

Hatha Yoga

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescents must have elevated depressive symptoms, defined by a score of 11 or higher on the Quick Inventory of Depression -Adolescent Version-- Clinician Rating (QIDS-A-CR), including endorsement of either sad mood or anhedonia on the QIDS.
  • Other treatment for depression must be stable at baseline. Adolescents do not have to be in other treatment for depression, but, if they are, it must be stable for the past 12 weeks.
  • Adolescents must be aged 13-18.
  • Adolescents must be medically cleared for moderate physical activity by their primary care physician. This criterion may be met by a current (dated in the past year) statement from their pediatrician that the adolescent may participate in school or camp programs including physical education.
  • Adolescents must be able to read and write English sufficient to complete informed consent and engage in interventions.
  • Adolescents aged 13-17 must assent to be in the study, and their parent or legal guardian must consent to their participation. Adolescents aged 18 must consent to be in the study.
  • Able to attend one of the class times.

You may not qualify if:

  • QIDS- A-CR may not be higher than a score of 21. This ensures that adolescents are not severely depressed.
  • Adolescents who meet criteria for:
  • Current (past year) autism spectrum disorder (AS), if of sufficient severity to interfere with study treatment per clinician judgment;
  • Schizophrenia;
  • Bipolar disorder;
  • Clinically significant psychotic symptoms in the past month;
  • Anorexia or Bulimia in past 3 months
  • Substance use disorders in the past 12 months and symptoms are of sufficient severity to interfere with study treatment per clinician judgment These will be assessed with the Mini-International Neuropsychiatric Interview (MINI).
  • Adolescents may not have current suicide ideation or behavior that warrants immediate treatment. They may have passive ideation (i.e., thoughts that life is not worth living), but may not have active suicide ideation, intent, plan, or an attempt within the previous 6 months.
  • Adolescents cannot currently be engaged in or yoga classes, as this is the study intervention.
  • Adolescents cannot be pregnant as yoga should be modified for pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Butler Hospital

Providence, Rhode Island, 02906, United States

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Results Point of Contact

Title
Dr. Lisa Uebelacker
Organization
Butler Hospital

Study Officials

  • Lisa Uebelacker, PhD

    Butler Hospital

    PRINCIPAL INVESTIGATOR
  • Shirley Yen, PhD

    Brown University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2019

First Posted

February 5, 2019

Study Start

March 1, 2019

Primary Completion

August 14, 2019

Study Completion

August 29, 2019

Last Updated

March 23, 2022

Results First Posted

March 23, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will share

All IPD underlying publication if required by journal.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
One year after study collection.
Access Criteria
Information available upon request, please send to PIs Lisa Uebelacker or Shirley Yen.

Locations